The role of the AT4 and cholinergic systems in the Nucleus Basalis Magnocellularis (NBM): Effects on spatial memory

Brain Research

Volumn 1272, Issue , 2009, Pages 25-31

  Wilson, Wendy L ^a   Munn, Christine ^a   Ross, Ryan C ^a   Harding, Joseph W ^a   Wright, John W ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

ACh receptor; Alzheimer's disease; Angiotensin; Learning; Memory; Nucleus Basalis

Indexed keywords

ANGIOTENSIN II [3-8]; ANGIOTENSIN RECEPTOR ANTAGONIST; CARBACHOL; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR; SCOPOLAMINE; ACETYLCHOLINE; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; AT4 RECEPTOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIVALINAL ANGIOTENSIN IV; DIVALINAL-ANGIOTENSIN IV; DRUG DERIVATIVE; NICOTINIC AGENT; NICOTINIC RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CHOLINERGIC SYSTEM; COGNITION; CONTROLLED STUDY; GIANT CELL; MALE; MAZE TEST; MEYNERT BASAL NUCLEUS; NONHUMAN; PARASYMPATHETIC INNERVATION; PRIORITY JOURNAL; RAT; SPATIAL MEMORY; ANALYSIS OF VARIANCE; ANIMAL; ANIMAL BEHAVIOR; BEHAVIOR; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; MEMORY; METABOLISM; PHYSIOLOGY; REACTION TIME; SPRAGUE DAWLEY RAT; TIME;

PRIMATES; RATTUS;

ACETYLCHOLINE; ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANIMALS; BASAL NUCLEUS OF MEYNERT; BEHAVIOR, ANIMAL; CARBACHOL; CHOLINERGIC ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MAZE LEARNING; MECAMYLAMINE; MEMORY; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTORS, ANGIOTENSIN; SCOPOLAMINE; SPATIAL BEHAVIOR; TIME FACTORS;

EID: 67349152761     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.03.025     Document Type: Article

References (32)

1. Albiston A.L., Pederson E.S., Burns P., Purcell B., Wright J.W., Harding J.W., et al. Attenuation of scopolamine-induced learning deficits by LVV-hemorphin-7 in rats in the passive avoidance and water maze paradigms. Behav. Brain Res. 154 1 (2004) 239-243
2. Arendt T., Bigl V., Tennstedt A., and Arendt A. Correlation between cortical plaque count and neuronal loss in the nucleus basalis in Alzheimer's disease. Neurosci. Lett. 48 1 (1984) 81-85
3. Braszko J.J., Kupryszewski G., Witczuk B., and Wisniewski K. Angiotensin II-(3-8)-hexapeptide affects motor activity, performance of passive avoidance and a conditioned avoidance response in rats. Neuroscience 27 3 (1988) 777-783
4. Buccafusco J.J., Letchworth S.R., Bencherif M., and Lippiello P.M. Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance. Trends Pharmacol. Sci. 26 7 (2005) 352-360
5. Bunce J.G., Sabolek H.R., and Chrobak J.J. Timing of administration mediates the memory effects of intraseptal carbachol infusion. Neuroscience 127 3 (2004) 593-600
6. De-Mello N., Souza-Junior I.Q., and Carobrez A.P. Pilocarpine prevents age-related spatial learning impairments in rats. Behav. Brain Res. 158 2 (2005) 263-268
7. Dekker A.J., Connor D.J., and Thal L.J. The role of cholinergic projections from the nucleus basalis in memory. Neurosci. Biobehav. Rev. 15 2 (1991) 299-317
8. Dennes R.P., and Barnes J.C. Attenuation of scopolamine-induced spatial memory deficits in the rat by cholinomimetic and non-cholinomimetic drugs using a novel task in the 12-arm radial maze. Psychopharmacology (Berl) 111 4 (1993) 435-441
9. Dickson C.T., and Vanderwolf C.H. Animal models of human amnesia and dementia: hippocampal and amygdala ablation compared with serotonergic and cholinergic blockade in the rat. Behav. Brain Res. 41 3 (1990) 215-227
10. Doucette R., Fisman M., Hachinski V.C., and Mersky H. Cell loss from the nucleus basalis of Meynert in Alzheimer's disease. Can. J. Neurol. Sci. 13 4 suppl (1986) 435-440
11. Flood J.F., and Cherkin A. Scopolamine effects on memory retention in mice: a model of dementia?. Behav. Neural Biol. 45 2 (1986) 169-184
12. Givens B., and Olton D.S. Local modulation of basal forebrain: effects on working and reference memory. J. Neurosci. 14 6 (1994) 3578-3587
13. Lee J., Chai S.Y., Mendelsohn F.A., Morris M.J., and Allen A.M. Potentiation of cholinergic transmission in the rat hippocampus by angiotensin IV and LVV-hemorphin-7. Neuropharmacology 40 4 (2001) 618-623
14. Lee J., Albiston A.L., Allen A.M., Mendelsohn F.A., Ping S.E., Barrett G.L., et al. Effect of I.C.V. injection of AT4 receptor ligands, NLE1-angiotensin IV and LVV-hemorphin 7, on spatial learning in rats. Neuroscience 124 2 (2004) 341-349
15. Markowska A.L., Olton D.S., and Givens B. Cholinergic manipulations in the medial septal area: age-related effects on working memory and hippocampal electrophysiology. J. Neurosci. 15 3 Pt 1 (1995) 2063-2073
16. Mesulam M.M. Some cholinergic themes related to Alzheimer's disease: synaptology of the nucleus basalis, location of m2 receptors, interactions with amyloid metabolism, and perturbations of cortical plasticity. J. Physiol. ( Paris ) 92 3-4 (1998) 293-298
17. Muir J.L. Acetylcholine, aging, and Alzheimer's disease. Pharmacol. Biochem. Behav. 56 4 (1997) 687-696
18. Newhouse P.A., Potter A., and Singh A. Effects of nicotinic stimulation on cognitive performance. Curr. Opin. Pharmacol. 4 1 (2004) 36-46
19. Olson M.L., Olson E.A., Qualls J.H., Stratton J.J., Harding J.W., and Wright J.W. Norleucine1-Angiotensin IV alleviates mecamylamine-induced spatial memory deficits. Peptides 25 2 (2004) 233-241
20. Olton D.S. Dementia: animal models of cognitive impairments following damage to the basal forebrain cholinergic systems. Brain Res. Bull. 25 3 (1990) 499-502
21. Patel S., and Tariot P.N. Pharmacologic models of Alzheimer's disease. Psychiatr. Clin. North Am. 14 2 (1991) 287-308
22. Pederson E.S., Harding J.W., and Wright J.W. Attenuation of scopolamine-induced spatial learning impairments by an angiotensin IV analog. Regul. Pept. 74 2-3 (1998) 97-103
23. Pederson E.S., Krishnan R., Harding J.W., and Wright J.W. A role for the angiotensin AT4 receptor subtype in overcoming scopolamine-induced spatial memory deficits. Regul. Pept. 102 2-3 (2001) 147-156
24. Rasool, C.G., Svendsen, C.N., Selkoe, D.J., (1986). Neurofibrillary degeneration of cholinergic and noncholinergic neurons of the basal forebrain in Alzheimer's disease. Ann. Neurol. 20 (4), 482-488.
25. Rouse S.T., Edmunds S.M., Yi H., Gilmor M.L., and Levey A.I. Localization of M(2) muscarinic acetylcholine receptor protein in cholinergic and non-cholinergic terminals in rat hippocampus. Neurosci. Lett. 284 3 (2000) 182-186
26. Sen A.P., and Bhattacharya S.K. Effect of selective muscarinic receptor agonists and antagonists on active-avoidance learning acquisition in rats. Indian J. Exp. Biol. 29 2 (1991) 136-139
27. Siniscalchi A., Badini I., Cintra A., Fuxe K., Bianchi C., and Beani L. Muscarinic modulation of acetylcholine release from slices of guinea pig nucleus basalis magnocellularis. Neurosci. Lett. 140 2 (1992) 235-238
28. Sweatt J.D. Hippocampal function in cognition. Pschopharmacology (Berlin). 174 1 (2004) 99-110
29. Volpicelli-Daley L.A., Duysen E.G., Lockridge O., and Levey A.I. Altered hippocampal muscarinic receptors in Acetylcholinesterase-deficient mice. Ann. Neurol. 53 6 (2003) 788-795
30. Wenk M., Biel V., and Meyer U. Cholinergic projections from magnocellar nuclei of the basal forebrain to cortical areas in rats. Brain Res. 2 3 (1980) 295-316
31. Wright J.W., Murphy E.S., Elijah I.E., Holtfreter K.L., Davis C.J., Olson M.L., et al. Influence of hippocampectomy on habituation, exploratory behavior, and spatial memory in rats. Brain Res. 1023 1 (2004) 1-14
32. Wright J.W., Stubley L., Pederson E.S., Kramar E.A., Hanesworth J.M., and Harding J.W. Contributions of the brain angiotensin IV-AT4 receptor subtype system to spatial learning. J. Neurosci. 19 10 (1999) 3952-3961